These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35961198)

  • 21. DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.
    Purcaro C; Vanacore N; Moret F; Di Battista ME; Rubino A; Pierandrei S; Lucarelli M; Meco G; Fattapposta F; Pascale E
    Neurosci Lett; 2019 Jan; 690():83-88. PubMed ID: 30316985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporalis Muscle Thickness as an Indicator of Sarcopenia Is Associated With Long-term Motor Outcomes in Parkinson's Disease.
    Chung SJ; Kim YJ; Yoo HS; Jung JH; Baik K; Lee HS; Lee YH; Hong JM; Sohn YH; Lee PH
    J Gerontol A Biol Sci Med Sci; 2021 Nov; 76(12):2242-2248. PubMed ID: 33754634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease.
    Chung SJ; Yoo HS; Lee YH; Jung JH; Baik K; Ye BS; Sohn YH; Lee PH
    Ann Clin Transl Neurol; 2020 Feb; 7(2):229-238. PubMed ID: 32032471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low skull bone density is associated with poor motor prognosis in women with Parkinson's disease.
    Jeong SH; Hong N; Lee HS; Han S; Lee YG; Lee Y; Rhee Y; Sohn YH; Lee PH
    Front Aging Neurosci; 2022; 14():1053786. PubMed ID: 36457758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.
    Jeong SH; Lee HS; Jung JH; Baik K; Sohn YH; Chung SJ; Lee PH
    Parkinsonism Relat Disord; 2022 Apr; 97():1-7. PubMed ID: 35276583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson's disease.
    Jeong SH; Chung SJ; Yoo HS; Hong N; Jung JH; Baik K; Lee YH; Sohn YH; Lee PH
    Brain; 2021 May; 144(4):1127-1137. PubMed ID: 33895825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off.
    Chung SJ; Lee Y; Oh JS; Kim JS; Lee PH; Sohn YH
    Parkinsonism Relat Disord; 2018 Aug; 53():96-100. PubMed ID: 29776864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premorbid Educational Attainment and Long-Term Motor Prognosis in Parkinson's Disease.
    Jeong SH; Chung SJ; Yoo HS; Jung JH; Baik K; Lee YH; Lee PH; Sohn YH
    J Parkinsons Dis; 2022; 12(1):129-136. PubMed ID: 34542032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?
    Chung SJ; Yoo HS; Lee HS; Jeong HE; Kim SJ; Oh JS; Kim JS; Sohn YH; Lee PH
    CNS Drugs; 2018 Oct; 32(10):971-979. PubMed ID: 30027399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease.
    Dadar M; Miyasaki J; Duchesne S; Camicioli R
    Parkinsonism Relat Disord; 2021 Apr; 85():95-101. PubMed ID: 33770671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Pattern of Striatal Dopamine Depletion as a Prognostic Marker in De Novo Parkinson Disease.
    Chung SJ; Yoo HS; Lee HS; Oh JS; Kim JS; Sohn YH; Lee PH
    Clin Nucl Med; 2018 Nov; 43(11):787-792. PubMed ID: 30153150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perivascular Spaces in the Basal Ganglia and Long-term Motor Prognosis in Newly Diagnosed Parkinson Disease.
    Chung SJ; Yoo HS; Shin NY; Park YW; Lee HS; Hong JM; Kim YJ; Lee SK; Lee PH; Sohn YH
    Neurology; 2021 Apr; 96(16):e2121-e2131. PubMed ID: 33653906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease.
    Kaplan N; Vituri A; Korczyn AD; Cohen OS; Inzelberg R; Yahalom G; Kozlova E; Milgrom R; Laitman Y; Friedman E; Rosset S; Hassin-Baer S
    J Mol Neurosci; 2014 Jun; 53(2):183-8. PubMed ID: 24633632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation.
    Simoni S; Paoletti FP; Eusebi P; Cappelletti G; Filidei M; Brahimi E; Nigro P; Santangelo V; Parnetti L; Calabresi P; Tambasco N
    J Parkinsons Dis; 2020; 10(3):927-934. PubMed ID: 32280105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Freezing of gait in patients with advanced Parkinson's disease.
    Giladi N; Treves TA; Simon ES; Shabtai H; Orlov Y; Kandinov B; Paleacu D; Korczyn AD
    J Neural Transm (Vienna); 2001; 108(1):53-61. PubMed ID: 11261746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic exposure to dopamine agonists affects the integrity of striatal D
    Politis M; Wilson H; Wu K; Brooks DJ; Piccini P
    Neuroimage Clin; 2017; 16():455-460. PubMed ID: 28879087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-dependent association of urate on the patterns of striatal dopamine depletion in Parkinson's disease.
    Baik K; Chung SJ; Yoo HS; Lee YH; Jung JH; Sohn YH; Lee PH
    Eur J Neurol; 2020 May; 27(5):773-778. PubMed ID: 31994785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.
    Dos Santos EUD; da Silva IIFG; Asano AGC; Asano NMJ; De Mascena Diniz Maia M; de Souza PRE
    Mol Biol Rep; 2020 Nov; 47(11):8997-9004. PubMed ID: 33151475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.